Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04VOZ
|
|||
| Former ID |
DNCL001744
|
|||
| Drug Name |
TKM-ApoB
|
|||
| Drug Type |
siRNA drug
|
|||
| Indication | Hypercholesterolaemia [ICD-11: 5C80.0] | Phase 4 | [1] | |
| Company |
Tekmira Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00348686) Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP). U.S. National Institutes of Health. | |||
| REF 2 | Current Progress of siRNA/shRNA Therapeutics in Clinical Trials. Biotechnol J. 2011 September; 6(9): 1130-1146. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.